Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000874015-22-000148
Filing Date
2022-08-09
Accepted
2022-08-09 15:56:06
Documents
60
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 IONIS PHARMACEUTICALS INC 10-Q 6-30-2022 form10q.htm   iXBRL 10-Q 2049633
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 75152
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 12901
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 12794
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 6990
11 image1.jpg GRAPHIC 11357
  Complete submission text file 0000874015-22-000148.txt   8607260

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ions-20220630.xsd EX-101.SCH 48619
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ions-20220630_cal.xml EX-101.CAL 80637
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ions-20220630_def.xml EX-101.DEF 299906
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20220630_lab.xml EX-101.LAB 773515
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20220630_pre.xml EX-101.PRE 416817
54 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1474441
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 221148049
SIC: 2834 Pharmaceutical Preparations